封面
市场调查报告书
商品编码
1886691

胰岛素输注帮浦市场-全球产业规模、份额、趋势、机会和预测,按组件(泵体、输注装置和储液器)、地区和竞争格局划分,2020-2030年预测

Insulin Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Pump Device, Infusion Set, and Reservoir), By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球胰岛素输注帮浦市场规模为15.5亿美元,预计到2030年将以6.50%的复合年增长率成长至22.6亿美元。胰岛素输注帮浦是一种医疗器械,可提供持续的皮下胰岛素输注,为糖尿病患者提供了一种替代每日多次注射的治疗方案。全球胰岛素输注帮浦市场的主要驱动因素是全球糖尿病盛行率的不断攀升,以及对能够改善患者预后的先进便捷血糖管理解决方案日益增长的需求。

市场概览
预测期 2026-2030
市场规模:2024年 15.5亿美元
市场规模:2030年 22.6亿美元
复合年增长率:2025-2030年 6.50%
成长最快的细分市场 泵浦装置
最大的市场 北美洲

主要市场驱动因素

全球胰岛素输注帮浦市场的扩张直接受到全球糖尿病诊断数量持续成长的影响。不断扩大的患者群体从根本上拓宽了先进血糖管理解决方案的潜在市场。

主要市场挑战

胰岛素输注帮浦的高昂成本,加上不同地区报销政策的差异和限制,严重阻碍了其市场扩张。这些先进医疗设备所需的高额前期投入,对许多患者而言构成了相当大的经济障碍,限制了他们获得这种有益的糖尿病管理方案的机会。

主要市场趋势

将人工智慧和机器学习应用于预测性胰岛素给药是一个关键趋势,它提高了胰岛素输注系统的精确度和自主性。这些智慧演算法分析即时血糖资料、生活方式因素和历史血糖模式,预测未来的血糖水平,并主动调整胰岛素输注量,从而预防低血糖和高血糖事件的发生。

目录

第一章:产品概述

第二章:研究方法

第三章:执行概要

第四章:顾客之声

第五章:全球胰岛素输注帮浦市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按组件(帮浦装置、输液器、储液器)
    • 按地区
    • 按公司(2024 年)
  • 市场地图

第六章:北美胰岛素输注帮浦市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章:欧洲胰岛素输注帮浦市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲:国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章:亚太地区胰岛素输注帮浦市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:中东和非洲胰岛素输注帮浦市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲:国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章:南美洲胰岛素输注帮浦市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲:国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章:市场动态

  • 司机
  • 挑战

第十二章:市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章:全球胰岛素输注帮浦市场:SWOT分析

第十四章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章:竞争格局

  • Medtronic plc
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG

第十六章:策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23537

The Global Insulin Infusion Pumps Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.26 Billion by 2030. Insulin infusion pumps are medical devices providing continuous subcutaneous insulin delivery, offering an alternative to multiple daily injections for managing diabetes mellitus. The global market for these devices is primarily driven by the escalating prevalence of diabetes worldwide, coupled with the increasing demand for advanced and convenient glycemic management solutions that enhance patient outcomes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.55 Billion
Market Size 2030USD 2.26 Billion
CAGR 2025-20306.50%
Fastest Growing SegmentPump Device
Largest MarketNorth America

Key Market Drivers

The global insulin infusion pumps market expansion is directly influenced by the persistent increase in worldwide diabetes diagnoses. This escalating patient demographic inherently broadens the addressable market for advanced glycemic management solutions. As more individuals are identified with diabetes, the demand for effective and less burdensome treatment modalities like insulin pumps intensifies, shifting away from conventional injection methods.

Key Market Challenges

The significant cost associated with insulin infusion pumps, coupled with varied and often limited reimbursement policies across different regions, presents a substantial impediment to market expansion. The high upfront investment required for these advanced medical devices creates a considerable financial barrier for many patients, restricting their access to this beneficial diabetes management option. This issue is particularly pronounced in developing economies, where healthcare infrastructure is less robust and patient affordability is a critical concern, leading to reduced adoption rates despite the clear clinical advantages.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning for predictive dosing represents a pivotal trend, enhancing the precision and autonomy of insulin delivery systems. These intelligent algorithms analyze real-time glucose data, lifestyle factors, and historical patterns to forecast future glucose levels, proactively adjusting insulin delivery to prevent both hypoglycemic and hyperglycemic events.

Key Market Players

  • Medtronic plc
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG

Report Scope:

In this report, the Global Insulin Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Insulin Infusion Pumps Market, By Component:

  • Pump Device
  • Infusion Set
  • Reservoir

Insulin Infusion Pumps Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Insulin Infusion Pumps Market.

Available Customizations:

Global Insulin Infusion Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Insulin Infusion Pumps Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Pump Device, Infusion Set, Reservoir)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Insulin Infusion Pumps Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Insulin Infusion Pumps Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
    • 6.3.2. Canada Insulin Infusion Pumps Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
    • 6.3.3. Mexico Insulin Infusion Pumps Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component

7. Europe Insulin Infusion Pumps Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Insulin Infusion Pumps Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
    • 7.3.2. France Insulin Infusion Pumps Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
    • 7.3.3. United Kingdom Insulin Infusion Pumps Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
    • 7.3.4. Italy Insulin Infusion Pumps Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
    • 7.3.5. Spain Insulin Infusion Pumps Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component

8. Asia Pacific Insulin Infusion Pumps Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Insulin Infusion Pumps Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
    • 8.3.2. India Insulin Infusion Pumps Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
    • 8.3.3. Japan Insulin Infusion Pumps Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
    • 8.3.4. South Korea Insulin Infusion Pumps Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
    • 8.3.5. Australia Insulin Infusion Pumps Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component

9. Middle East & Africa Insulin Infusion Pumps Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Insulin Infusion Pumps Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
    • 9.3.2. UAE Insulin Infusion Pumps Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
    • 9.3.3. South Africa Insulin Infusion Pumps Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component

10. South America Insulin Infusion Pumps Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Insulin Infusion Pumps Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
    • 10.3.2. Colombia Insulin Infusion Pumps Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
    • 10.3.3. Argentina Insulin Infusion Pumps Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Insulin Infusion Pumps Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Insulet Corporation
  • 15.3. Ascensia Diabetes Care Holdings AG
  • 15.4. Tandem Diabetes Care, Inc.
  • 15.5. Ypsomed Holding AG

16. Strategic Recommendations

17. About Us & Disclaimer